openPR Logo
Press release

Rising Incidence of Chronic Diseases Driving Demand for Pharmaceutical Filtration Techniques

12-10-2021 11:06 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: P&S Intelligence

Rising Incidence of Chronic Diseases Driving Demand

With the rising incidence of various chronic diseases, the governments of many countries are making huge investments in the healthcare industry and taking initiatives for facilitating improvements in the healthcare infrastructure. According to the World Health Organization (WHO), the surge in healthcare expenditure is fueling rapid improvements in healthcare infrastructure and greater focus on research and development (R&D) activities, which is subsequently pushing up the requirement for pharmaceutical filtration methods across the world.

Receive Sample Pages of this Report:https://www.psmarketresearch.com/market-analysis/pharmaceutical-filtration-market/report-sample

Moreover, many countries are investing a major portion of their gross domestic product (GDP) on healthcare. In the developed nations of North America and Europe, healthcare spending is considerably higher than that in the developing countries, on account of their lower income per capita GDP. However, the situation is expected to change in the coming years, with the governments of many emerging economies aiming to increase their healthcare expenditure in the forthcoming years, on account of the rising incidence of diseases.

Make an Enquiry before Purchase:https://www.psmarketresearch.com/send-enquiry?enquiry-url=pharmaceutical-filtration-market

The pharmaceutical filtration market is divided, depending on product, into membrane filters, prefilters and depth media filters, single-use systems, filtration accessories, cartridge and capsule filters, and filter holders. Amongst these, the membrane filters category held the largest share in the market in 2016, as per the observations of the market research company, P&S Intelligence. This is credited to the increasing use of membrane filters for pharmaceutical filtration, as they can be easily deployed in small and large laboratories.

Globally, North America contributed the highest revenue to the pharmaceutical filtration market in 2016. The U.S. dominated the regional market during the last few years. This was because of the high incidence of lifestyle-associated and chronic diseases, the presence of a large geriatric population, and high biopharmaceutical production in the region. Likewise, the U.K. held the largest share in the European market in the past years and it was followed by Germany and France.

About P&S Intelligence
P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rising Incidence of Chronic Diseases Driving Demand for Pharmaceutical Filtration Techniques here

News-ID: 2493297 • Views:

More Releases from P&S Intelligence

U.S. ESG Investments Market Set to Skyrocket: $16 Trillion by 2032
U.S. ESG Investments Market Set to Skyrocket: $16 Trillion by 2032
According to the latest market research study published by P&S Intelligence, the U.S. Environmental, Social, and Governance (ESG) investments market is experiencing a significant surge, with projections indicating an increase from $6.5 trillion in 2024 to an estimated $16.0 trillion by 2032. This represents a robust compound annual growth rate (CAGR) of 12.1% over the forecast period. According to a comprehensive analysis by P&S Intelligence, the market's expansion is driven
Facility Management in the U.K. Booms with 14.1% CAGR as Demand Soars Across Sectors
Facility Management in the U.K. Booms with 14.1% CAGR as Demand Soars Across Sec …
According to the latest market research study published by P&S Intelligence, the U.K. facility management market is poised for significant growth, with projected revenues reaching USD 2,743.3 million in 2024 and expected to soar to USD 6,038.4 million by 2030, reflecting a robust CAGR of 14.1% during the forecast period. This expansion is fueled by a surge in demand across both public and private sectors. According to the RICS U.K.
Point-of-Sale Software Market in the U.S. Set to Grow by 9.7% CAGR, Boosted by Omnichannel Integration
Point-of-Sale Software Market in the U.S. Set to Grow by 9.7% CAGR, Boosted by O …
According to the latest market research study published by P&S Intelligence, the U.S. point-of-sale (POS) software market, valued at USD 4.7 billion in 2024, is poised for significant growth over the coming years, with projections estimating it will reach USD 9.8 billion by 2032, expanding at a compound annual growth rate (CAGR) of 9.7%. This growth is attributed to rapid technological advancements, a surge in mobile and cloud-based POS systems,
Competitive Landscape of the Industrial Starches Market: Key Players, Trends, and Growth Opportunities
Competitive Landscape of the Industrial Starches Market: Key Players, Trends, an …
According to the latest market research study published by P&S Intelligence, the global industrial starches market is poised for significant growth, with a projected increase from USD 110.3 billion in 2024 to USD 169.9 billion by 2030, at a robust compound annual growth rate (CAGR) of 7.5%. Industrial starches play a crucial role in diverse sectors, including food, pharmaceuticals, and paper, driven by their unique properties such as stabilizing, thickening,

All 4 Releases


More Releases for GDP

China's GDP Surprises on Buoyant Demand
Economists are becoming more positive on this year's economic prospects. Image: https://www.getnews.info/uploads/00fca63e211ffb8a1956472d8f5965db.jpg In its April World Economic Outlook (WEO), the IMF now forecasts aggregate GDP growth to reach 3.2 percent this year, up 0.3 percentage points from its October projection. The Fund describes the global economy as "surprisingly resilient [https://www.imf.org/en/Publications/WEO/Issues/2024/04/16/world-economic-outlook-april-2024?cid=ca-com-homepage-SM2024]" for the way in which it has continued to grow despite the higher interest rates needed to rein in inflation. In this vein,
Quantta Analytics collaborates with NITI Aayog to predict GDP growth rate of Ind …
Traditionally released by the Central Statistical Office (CSO) of the Government of India, Quantta has used its extensive database on the Indian Economy to provide an advance signal to senior leaders in Government about the state of the economy. Using data from several sectors, that drive growth, it predicted a First Quarter growth rate of 7.83% indicating that the Indian Economy is firing on all cylinders. The actual numbers released
IATA's CEIV-Pharma Certification or HSA's GDP Certification?
Players throughout the pharmaceutical supply chain are experiencing growing pressure to gain accreditation for handling the high-value, temperature-sensitive cargo, as having a certification becomes more commonplace, rather than an exceptional feat in the industry. There are currently 2 different measures of standards, one is IATA's CEIV-Pharma Certification and the other is HSA's GDP Certification. There are major players on both sides of the fence which hold – GDP-compliant certificates and CEIV-pharma certifications.
European GDP Association nominates new Advisory Board Member
So far the Board of the European GDP Association comprised four members from the industry side, supported by a representative from the Finnish Medicines Agency FIMEA. Now a new Board Member has been nominated on the industry side. Dr Laura Ribeiro, who is a Responsible Person at ID Logistics (formerly Logiters) in Portugal, has recently accepted her nomination as the fifth member of the GDP Association's Board. Prior to her
US GDP Up 1.7% Shattering Economists Predictions
Aug. 01, 2013 - HONG KONG -- On Wednesday the US Commerce Department released its highly anticipated report on GDP, stating that in the second quarter the US economy grew 1.7% driven by an increase of 1.8% in consumer spending and 9% in business investment. New home construction was another important driver of growth, with investment rising 13.4%, the fourth consecutive increase. This gain beat expectations of a 1%
Taiwan's GDP growth to hit fastest pace in 21 years
By Audrey Wang The Economist Intelligence Unit expects Taiwan’s gross domestic product to grow by 9.2 percent in 2010, the fastest rate in 21 years, according to the Council for Economic Planning and Development Sept. 24. The EIU report noted that Taiwan’s economy grew by an average of 13.1 percent in the first two quarters of 2010. This stellar performance, the EIU said, “largely reflects the global economy’s return to